The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Regulation of the G2/M transition by p53
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, as a p53 target gene and member of the growth arrest gene family, GADD45 expression is regulated by p53 to induce G2 phase arrest.60”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [60]
In the citing paper
“p53 represses CDKs and cyclin B, which are required for entry into mitosis and are involved in G2/M phase block.62,63”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [63]
In the citing paper
“p53 regulates the transcription of Gadd45, disrupts the cyclin B1/Cdc2 complex, and further blocks the G2 phase.63,65”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,021
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,831
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
A role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046
(1999) · PubMed · Cited by 1,030
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858 · cited 3×
“We have used a di erent system to study the role of p53 in G2 arrest. p53-null human ®broblasts reconstituted with a tetracyline-regulated p53 minigene were synchronized with mimosine, which blocks them reversibly at the beginning of S phase (Agarwal et al., 1995).”
BackgroundMethodSelf-citationAtaxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
Inactivation of the p34 cdc2 -Cyclin B Complex by the Human WEE1 Tyrosine Kinase
Parker, L. L., & Piwnica-Worms, H. (1992) · Science · doi:10.1126/science.1384126 · Cited by 716
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 669
GADD45 induction of a G 2 /M cell cycle checkpoint
Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634
Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.
Chehab, N. H., Malikzay, A., Stavridi, E. S., & Halazonetis, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13777 · Cited by 583
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein
Lopez-Girona, A., Furnari, B., Mondesert, O., & Russell, P. (1999) · Nature · doi:10.1038/16488 · Cited by 576
Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., & Piwnica-Worms, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5600 · Cited by 544
Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase
Furnari, B., Rhind, N., & Russell, P. (1997) · Science · doi:10.1126/science.277.5331.1495 · Cited by 539
Cyclins and cyclin-dependent kinases: a biochemical view
Pines, J. (1995) · Biochemical Journal · doi:10.1042/bj3080697 · Cited by 538
Cliby, W. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 536
Genomic instability in Gadd45a-deficient mice
Hollander, M. C., Sheikh, M. S., Bulavin, D. V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro, T. A., Kim, K. E., Tolosa, E., Ashwell, J. D., et al. (1999) · Nature Genetics · doi:10.1038/13802 · Cited by 510
Ostareck, D. H., Ostareck-Lederer, A., Wilm, M., Thiele, B. J., Mann, M., & Hentze, M. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80241-x · Cited by 502
Zhan, Q., Antinore, M. J., Wang, X. W., Carrier, F., Smith, M. L., Harris, C. C., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202667 · Cited by 474
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53
Wang, Q., Fan, S., Eastman, A., Worland, P. J., Sausville, E. A., & O'Connor, P. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.956 · Cited by 453
Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle.
Watanabe, N., Broome, M., & Hunter, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07180.x · Cited by 450
CDC5 and CKII Control Adaptation to the Yeast DNA Damage Checkpoint
Toczyski, D. P., Galgoczy, D. J., & Hartwell, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80375-x · Cited by 436
p53 regulates a G 2 checkpoint through cyclin B1
Innocente, S. A., Abrahamson, J. L. A., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 436
Hurford, R. K., Cobrinik, D., Lee, M. H., & Dyson, N. (1997) · Genes & Development · doi:10.1101/gad.11.11.1447 · Cited by 431
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202925 · Cited by 423
Liu, F., Stanton, J. J., Wu, Z., & Piwnica-Worms, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.571 · Cited by 376
Nuclear Accumulation of p21 Cip1 at the Onset of Mitosis: a Role at the G 2 /M-Phase Transition
Dulić, V., Stein, G. H., Far, D. F., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.546 · Cited by 353
Heterogeneous Nuclear Ribonucleoprotein K Is a Transcription Factor
Michelotti, E. F., Michelotti, G. A., Aronsohn, A. I., & Levens, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2350 · Cited by 353
MPF localization is controlled by nuclear export
Hagting, A., Karlsson, C., Clute, P., Jackman, M., & Pines, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4127 · Cited by 334
Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint
Toyoshima, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2728 · Cited by 328
Control of Cyclin B1 localization through regulated binding of the nuclear export factor CRM1
Yang, J., Bardes, E. S. G., Moore, J. D., Brennan, J., Powers, M. A., & Kornbluth, S. (1998) · Genes & Development · doi:10.1101/gad.12.14.2131 · Cited by 323
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
Mack, D. H., Vartikar, J., Pipas, J. M., & Laimins, L. A. (1993) · Nature · doi:10.1038/363281a0 · Cited by 322 · cited 1×
“Repression can be due to squelching, whereby high levels of p53 bind to TATA-binding protein-associated factors (TAFs), sequestering them away from the promoters of genes that do not contain p53-binding sites (Farmer et al., 1996; Mack et al., 1993; Ragimov et al., 1993).”
BackgroundZwicker, J., Lucibello, F. C., Wolfraim, L. A., Gross, C., Truss, M., Engeland, K., & Müller, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00130.x · Cited by 322
Caffeine-Induced Uncoupling of Mitosis from the Completion of DNA Replication in Mammalian Cells
Schlegel, R., & Pardee, A. B. (1986) · Science · doi:10.1126/science.2422760 · Cited by 320
Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity
Booher, R. N., Holman, P. S., & Fattaey, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22300 · Cited by 313
Kumagai, A., & Dunphy, W. G. (1999) · Genes & Development · doi:10.1101/gad.13.9.1067 · Cited by 305
Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage
Jin, P., Hardy, S., & Morgan, D. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.875 · Cited by 298
Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
Izumi, T., & Maller, J. L. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1337 · Cited by 298
Caffeine inhibits the checkpoint kinase ATM
Blasina, A., Price, B. D., Turenne, G. A., & McGowan, C. H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80486-2 · Cited by 295
Vairo, G., Livingston, D. M., & Ginsberg, D. (1995) · Genes & Development · doi:10.1101/gad.9.7.869 · Cited by 293
Zhou, B.-B. S., Chaturvedi, P., Spring, K., Scott, S. P., Johanson, R. A., Mishra, R., Mattern, M. R., Winkler, J. D., & Khanna, K. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10342 · Cited by 278
Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein
Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J. (1995) · Science · doi:10.1126/science.7624774 · Cited by 275
Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP
Zheng, N., Fraenkel, E., Pabo, C. O., & Pavletich, N. P. (1999) · Genes & Development · doi:10.1101/gad.13.6.666 · Cited by 271
Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F., Dombkowski, D., Tang, W., & Friend, S. H. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)97825-l · Cited by 268
Cooperative effects of genes controlling the G2/M checkpoint
Chan, T. A., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 262
Association of p300 and CBP with Simian Virus 40 Large T Antigen
Eckner, R., Ludlow, J. W., Lill, N. L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J. A., Livingston, D. M., & Morgan, J. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3454 · Cited by 243
Identification of two KH domain proteins in the alpha-globin mRNP stability complex.
Kiledjian, M., Wang, X., & Liebhaber, S. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00110.x · Cited by 242
Target gene specificity of E2F and pocket protein family members in living cells
Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M., & Farnham, P. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5797-5807.2000 · Cited by 229
p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005437200 · Cited by 221
Guadagno, T. M., & Newport, J. W. (1996) · Cell · doi:10.1016/s0092-8674(00)80994-0 · Cited by 221
Moore, J. D., Yang, J., Truant, R., & Kornbluth, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.213 · Cited by 219
Smith, E. J., Leone, G., DeGregori, J., Jakoi, L., & Nevins, J. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6965 · Cited by 218
Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase
Ohki, R., Nemoto, J., Murasawa, H., Oda, E., Inazawa, J., Tanaka, N., & Taniguchi, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000235200 · Cited by 208
The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
Jin, S., Antinore, M. J., Lung, F.-D. T., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000284200 · Cited by 202
Mechanisms of G2 Arrest in Response to Overexpression of p53
Taylor, W. R., DePrimo, S. E., Agarwal, A., Agarwal, M. L., Schönthal, A. H., Katula, K. S., & Stark, G. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3607 · Cited by 195
Self-citationGao, Q., Srinivasan, S., Boyer, S. N., Wazer, D. E., & Band, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.733 · Cited by 188
Molecular Cloning and Expression of the Transformation Sensitive Epithelial Marker Stratifin
Leffers, H., Madsen, P., Rasmussen, H. H., Honore, B., Andersen, A. H., Walbum, E., Vandekerckhove, J., & Celis, J. E. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1346 · Cited by 180
Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
Bates, S., Ryan, K. M., Phillips, A. C., & Vousden, K. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202104 · Cited by 176
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168
Tommasi, S., & Pfeifer, G. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6901 · Cited by 163
Medema, R. H., Klompmaker, R., Smits, V. A., & Rijksen, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201558 · Cited by 161
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
Diverse molecular interactions of the hnRNP K protein
Bomsztyk, K., Van Seuningen, I., Suzuki, H., Denisenko, O., & Ostrowski, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00041-0 · Cited by 161
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H.-D., Choy, H. E., Chung, J., Yoo, H.-S., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 159
Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor
Wang, Q., Zambetti, G. P., & Suttle, D. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.389 · Cited by 152
Cdc25 protein phosphatases in cell proliferation
Draetta, G. F., & Eckstein, J. W. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00049-2 · Cited by 148
Avantaggiati, M. L., Carbone, M., Graessmann, A., Nakatani, Y., Howard, B. H., & Levine, A. S. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00577.x · Cited by 145
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
Thompson, D. A., Belinsky, G. S., Chang, T. H., Jones, D. L., Schlegel, R., & Münger, K. (1997) · Oncogene · doi:10.1038/sj.onc.1201495 · Cited by 120
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116 · cited 4×
“In contrast the expression of HPV-E6 in human foreskin ®broblasts did not a ect G2 arrest in response to ionizing radiation initially (Filatov et al., 1998; Kaufmann et al., 1997; Passalaris et al., 1999; Paules et al., 1995).”
BackgroundInfluentialZhu, J., & Chen, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5602-5618.2000 · Cited by 116
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110 · cited 6×
“Oncogene Repression of the cdc2 promoter by p53 requires a second region of *20 bp very close to the start of transcription, the R box, which acts as a silencer that can confer p53-dependent repression on heterologous promoters containing upstream AP-1 or SP1 binding sites (Taylor et al., 2001).”
BackgroundInfluentialSelf-citationSteinmann, K. E., Belinsky, G. S., Lee, D. H.-Y., & Schlegel, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6843 · Cited by 102
Utrera, R., Collavin, L., Lazarević, D., Delia, D., & Schneider, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5015 · Cited by 98
Filatov, L. V., Golubovskaya, V., Hurt, J. C., Byrd, L. L., Phillips, J. M., & Kaufmann, W. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201711 · Cited by 88
p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene
Sandri, M., Isaacs, R., Ongkeko, W. M., Harris, A. L., Hickson, I. D., Broggini, M., & Vikhanskaya, F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.22.4464 · Cited by 88
p53 inhibits entry into mitosis when DNA synthesis is blocked
Taylor, W. R., Agarwal, M. L., Agarwal, A. M., Stacey, D. W., & Stark, G. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202516 · Cited by 88
Self-citationRegulation of CAK kinase activity by p53
Schneider, E., Montenarh, M., & Wagner, P. (1998) · Oncogene · doi:10.1038/sj.onc.1202504 · Cited by 85
Ran-independent nuclear import of cyclin B1–Cdc2 by importin β
Takizawa, C. G., Weis, K., & Morgan, D. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7938 · Cited by 85
Chang, T. H., Ray, F. A., Thompson, D. A., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201196 · Cited by 84
Toledo, S. D., Azzam, E. I., Keng, P. C., Laffrenier, S., & Little, J. B. (1998) · PubMed · Cited by 74
Farmer, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4281 · Cited by 74
Winters, Z., Ongkeko, W. M., Harris, A. L., & Norbury, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201991 · Cited by 71
Tang, H.-Y. J., Zhao, K., Pizzolato, J. F., Fonarev, M., Langer, J., & Manfredi, J. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29156 · Cited by 70
Role of wild type p53 in the G2 phase: regulation of the γirradiation-induced delay and DNA repair
Schwartz, D., Almog, N., Peled, A., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201436 · Cited by 69
Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia
Rudolph, N. S., & Latt, S. A. (1989) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(89)90104-8 · Cited by 68
CDC2 is down-regulated by ionizing radiation in a p53-dependent manner.
Azzam, E. I., Toledo, S. D., Pykett, M. J., Nagasawa, H. T., & Little, J. B. (1997) · PubMed · Cited by 63
Sugarman, J. L., Schönthal, A. H., & Glass, C. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3282 · Cited by 43
The Molecular Basis and Clinical Management of Ataxia Telangiectasia
Spacey, S. D., Gatti, R. A., & Bebb, G. D. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000822 · Cited by 41
The NIMA kinase: A mitotic regulator in Aspergillus nidulans and vertebrate cells
Lu, K. P., & Hunter, T. R. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_15 · Cited by 41
Imai, T., Matsuda, K., Shimojima, T., Hashimoto, T., Masuhiro, Y., Kitamoto, T., Sugita, A., Suzuki, K., Matsumoto, H., Masushige, S., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6531 · Cited by 38
McShea, A., Samuel, T., Eppel, J.-T., Galloway, D. A., & Funk, J. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001772200 · Cited by 37
Hitomi, M., Shu, J., Agarwal, M. L., Agarwal, A. M., & Stacey, D. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202005 · Cited by 30
Cited by
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Metadata
- Authors
- Taylor, W. R., & Stark, G. R.
- Venue
- Oncogene
- Published
- 2001-04-05
- Volume
- 20
- Issue
- 15
- Pages
- 1803-1815
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1967880683
- Cited by
- 1,559
- References
- 110
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.